Clinical trial

Psilocybin for Methamphetamine Use Disorder

Peter HendricksNot yet recruitingPhase 2Started Feb 1, 202742 enrolledUnited StatesNCT07774702

Abstract

This trial tests whether psilocybin-assisted treatment can help adults stop using methamphetamine. Participants receive a single oral dose of psilocybin during a supervised session, paired with brief cognitive behavioral therapy, and are followed for up to six months. The study is supported by the HEAL Initiative (https://www.nih.gov/heal).

Topics & conditions

Detected automatically by Psychedelic Commons from the title and abstract, not labels from the source. They may be incomplete.

PsilocybinAddiction

Keywords

methamphetamineHEAL Initiativepsychedelic-assisted therapysubstance use disorderMethamphetamine Use Disorder

View on registry

Psychedelic Commons aggregates metadata from open sources and links back to the original. Rights remain with the authors and publishers. Something wrong with this record? Report a problem.

Related research

PreprintPsilocybin

Confirmatory factor analysis of Mystical Experience in Freediving as a recreative way to higher efficiency in sport performance and planet saving and money making

Mitina O, Mirsaidov M, Molchanova N +1

Europe PMC2020

ArticlePsilocybin

Pharmacotherapy to Prevent Alcohol Relapse in Alcohol-Associated Liver Disease.

Zhang W, Hwang SY, Luther J

Europe PMC2025

ArticlePsilocybin

Psychedelic substitution: altered substance use patterns following psychedelic use in a global survey.

Glynos NG, Aday JS, Kruger D +3

Europe PMC2024